Natural History Study to Understand and Measure Primary Mitochondrial Myopathy Progression
Led by Children's Hospital of Philadelphia · Updated on 2026-09-17
1300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying primary mitochondrial myopathy PMM to develop and validate tools that measure disease progression. This observational study aims to create and improve objective outcome measures, define the natural history of PMM, and compare data from affected patients to healthy controls. Understanding the clinical course and variability in PMM is essential for better clinical trial design and drug approval.
Participants include those with PMM confirmed by genetic or biochemical tests or as determined by clinical presentation, as well as healthy controls without symptoms. The study involves clinical exams of muscle strength, endurance, and surveys. Data from healthy controls help establish normal reference values for future research.
During the study, participants will undergo muscle strength, balance, and dexterity assessments, as well as evaluations of disease burden and functional abilities over an average of five years. Researchers will track clinical progression through survival, growth, illnesses, hospitalizations, and support needs. Patient-reported outcomes and qualitative interviews will also be collected to understand daily challenges and quality of life.
CONDITIONS
Brief Title
Natural History Study of Mitochondrial Myopathy
Research Team
K
Katelynn Stanley, BS
J
Jean Flickinger, PT
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with mitochondrial disorder confirmed by genetic or biochemical testing or suitable for participation based on clinical presentation
Exhibits myopathy symptoms related to mitochondrial disease such as exercise intolerance, muscle weakness, or fatigue
Able to provide written consent, or parental permission and child assent, or have a legally authorized representative for consent
Healthy controls: males or females aged 0 to 100 years with no history of mitochondrial myopathy symptoms
Healthy controls able to provide written consent or parental permission and child assent
Healthy controls are not study staff members or family of study staff
You will not qualify if you...
Male or female fetuses
Non-English speakers
Individuals deemed non-compliant with study schedules or procedures by the investigator
Healthy controls with confirmed mitochondrial disorder or myopathy symptoms
Healthy controls who are study staff or family members of study staff
Individuals who do not meet all enrollment criteria
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - Up to 5 years
Participants undergo regular clinical exams to assess muscle strength, balance, dexterity, and functional abilities. Surveys and interviews are completed to understand disease burden and daily challenges.
Periodic visits over study duration
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Study Evaluating KL1333 to Reduce Fatigue and Improve Physical Function in Adults with Primary Mitochondrial Disease
Natural History Study to Understand and Measure Primary Mitochondrial Myopathy Progression
Brain Chemical and Function Study in People Aged 8 to 75 With Primary Mitochondrial Disease and Healthy Volunteers